GLRE · Greenlight Capital Re, Ltd.
$16.98
+0.63 (+3.82%)
At close · Jul 24
Market Cap
$563.50M
Shares
33.17M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$729.78M
+4.8%
FY2025
Net Income
$74.83M
+74.8%
FY2025
Diluted EPS
$2.17
+75%
FY2025
Operating Cash Flow
$210.21M
+88.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $706.14M | $729.78M | $696.03M | $667.08M | $526.68M | $588.55M | $484.09M | $538.15M | $183.03M | $645.68M | $588.37M | $123.05M | $477.23M | $765.09M | $545.4M | $403.15M | |
| -$989K | — | — | — | -$6.72M | -$11.66M | — | — | — | — | — | — | — | — | — | — | |
| $646.83M | $661.14M | $619.95M | $583.15M | $469.48M | $539.28M | $455.41M | $483.58M | $508.36M | $626M | $513.12M | $408.39M | $354.24M | $547.9M | $466.71M | $379.78M | |
| $46.93M | — | — | $43.24M | $31.61M | $29.37M | $26.4M | $29.82M | $25.17M | $26.36M | $25.81M | $23.43M | $21.93M | $21.72M | $17.54M | $13.89M | |
| $6.26M | — | — | — | — | — | $6.28M | $6.26M | — | — | — | — | — | — | — | — | |
| $37.2M | $35.71M | $33.61M | $28.7M | $0 | $0 | $843K | $700K | -$247K | — | — | — | — | — | — | — | |
| -$11.44M | -$11.71M | -$918K | $1.74M | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $78.31M | — | — | — | — | — | -$79.21M | -$354M | -$44.83M | $47.21M | -$333.69M | $112.65M | $233.01M | $18.54M | $8.81M | |
| $2.31M | $3.48M | $749K | $100K | -$816K | $3.75M | $424K | $483K | $332K | -$451K | $509K | -$1.76M | -$624K | $538K | $86K | $247K | |
| $80.96M | $74.83M | $42.82M | $86.83M | $25.34M | $17.58M | $3.87M | -$3.99M | -$350.05M | -$44.95M | $44.88M | -$326.43M | $109.59M | $225.7M | $14.6M | $6.77M | |
| — | 10.25% | 6.15% | 13.02% | 4.81% | 2.99% | 0.8% | -0.74% | -191.26% | -6.96% | 7.63% | -265.28% | 22.96% | 29.5% | 2.68% | 1.68% | |
| — | — | — | — | — | — | — | $0 | -$4.28M | $578K | — | — | — | — | — | — | |
| $80.96M | $74.83M | $42.82M | $86.83M | $25.34M | — | — | — | — | — | — | — | — | — | — | — | |
| USD/shares | — | $2.21 | $1.26 | $2.55 | $0.75 | $0.51 | $0.11 | -$0.11 | -$9.74 | -$1.21 | $1.20 | -$8.90 | $2.94 | $6.13 | $0.40 | $0.19 |
| USD/shares | — | $2.17 | $1.24 | $2.50 | $0.73 | $0.51 | $0.11 | -$0.11 | -$9.74 | -$1.21 | $1.20 | -$8.90 | $2.89 | $6.01 | $0.39 | $0.18 |
| shares | — | 33.82M | 34.1M | 34.07M | 33.91M | 34.2M | 36.17M | 36.08M | 35.95M | 37M | 37.27M | 36.67M | 37.24M | 36.84M | 36.7M | 36.55M |
| shares | — | 34.5M | 34.65M | 34.8M | 39.77M | 34.35M | 36.28M | 36.08M | 35.95M | 37M | 37.34M | 36.67M | 37.87M | 37.59M | 37.36M | 37.29M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2015–FY2025: $82.14M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
7.20×
Peer median 6.16×
Peer medians compare against the 4 similar-size Insurance - Reinsurance companies (of 8 listed).
Valuation over time computed as of each quarter's filing date
Key facts
CIK
1385613
CUSIP
G4095J109
13F (30d)
21 filings
21 filers
Visit website
Investor relations